Published in Telemedicine Business Week, November 7th, 2007
"Previously, a benzyl-DTPA conjugate of Z(HER2:342) was labeled with In-111 and demonstrated good targeting in murine xenografts. We considered that the use of the macrocyclic chelator DOTA could increase the label stability and enhance a choice of nuclides, which could be used as a label for Z(HIR2:342). The goal of this study was the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week